4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-049552
Chief Executive Officer sold 164,834 shares at $14.45 ($2,381,851)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2018-08-31 | Sale | −100,000 | $14.45 | $1,445,000 | 1,868,789 | D |
| Anzalone Christopher Richard Chief Executive Officer | 2018-09-04 | Sale | −64,834 | $14.45 | $936,851 | 1,803,955 | D |
| Open-market sales · 164,834 sh · avg $14.45 · $2,381,851 | |||||||
Loading xslF345X03/doc4.xml…